vaginal hyaluronic acid/lactic acid-based formulation IC-LC02S2Q2

{
  "id": "MLC-T-ONC-017445",
  "term": "vaginal hyaluronic acid/lactic acid-based formulation IC-LC02S2Q2",
  "field": "Oncology and biomedicine",
  "definition": "A topical formulation containing hyaluronic acid and lactic acid, with vaginal healing, soothing, protective and immunomodulating activities. Upon intravaginal application of the hyaluronic acid/lactic acid-based formulation IC-LC02S2Q2, the hyaluronic acid enhances barrier integrity and barrier protection, reduces vaginal dryness while keeping the microbiome and pH levels normal. Lactic acid may protect the vagina by providing an acidic environment, which restores pH balance, helps provide an optimal vaginal microbiota, and enhances barrier integrity. This leads to immunomodulation and may prevent inflammation and infection. Altogether, this prevents vaginal itching, burning, bleeding, discomfort, and an unpleasant odor.",
  "synonyms": [
    "vaginal hyaluronic acid/lactic acid IC-LC02S2Q2",
    "topical hyaluronic acid/lactic acid IC-LC02S2Q2"
  ],
  "references": [
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/vaginal-hyaluronic-acid-lactic-acid-based-formulation-ic-lc02s2q2/"
}